(Q43678441)

English

Early improvement as a predictor of treatment response and remission in patients with schizophrenia: a pooled, post-hoc analysis from the asenapine development program

scientific article published on 15 January 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

0 references

Early improvement as a predictor of treatment response and remission in patients with schizophrenia: a pooled, post-hoc analysis from the asenapine development program (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

based on heuristic

inferred from title

author name string

Stefan Leucht

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Jun Zhao

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

15 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Journal of Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

387-394

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

Early onset of antipsychotic response in the treatment of acutely agitated patients with psychotic disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

Placebo-related effects in clinical trials in schizophrenia: what is driving this phenomenon and what can be done to minimize it?

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

Remission in schizophrenia: proposed criteria and rationale for consensus

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

Clinical, functional, and economic ramifications of early nonresponse to antipsychotics in the naturalistic treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

Optimizing early prediction for antipsychotic response in schizophrenia.

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

Early Prediction of Antipsychotic Response in Schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

Efficacy and safety of asenapine in a placebo- and haloperidol-controlled trial in patients with acute exacerbation of schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

Evidence for onset of antipsychotic effects within the first 24 hours of treatment

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

Early- and delayed antipsychotic response and prediction of outcome in 528 severely impaired patients with schizophrenia treated with amisulpride

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

What's next after 50 years of psychiatric drug development: an FDA perspective

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

Definitions of response and remission in schizophrenia: recommendations for their use and their presentation

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

The relative sensitivity of the Clinical Global Impressions Scale and the Brief Psychiatric Rating Scale in antipsychotic drug trials.

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

What does the PANSS mean?

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

Predicting antipsychotic drug response - replication and extension to six weeks in an international olanzapine study

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

Should the PANSS be rescaled?

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis.

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

Depression and antidepressant therapy: receptor dynamics

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

Selection Bias in Clinical Trials With Antipsychotics

1 reference

https://api.crossref.org/works/10.1177%2F0269881113517956

21 January 2018

Identifiers

10.1177/0269881113517956

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43678441&oldid=2102443498"